- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05396313
Prediction of Mortality After CIED Implantation (PM-CIED) (PM-CIED)
October 25, 2022 updated by: Yixiu Liang, Shanghai Zhongshan Hospital
Development and Validation of Predictive Models for Mortality After CIED Implantation
The study aims to develop and validate predictive models for the mortality of patients receiving CIED (including CRT and ICD) implantation.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The study aims to develop and validate predictive models for the mortality of patients receiving cardiovascular implantable electronic devices (CIED) [including cardiac resynchronization therapy (CRT) and implantable cardioverter defibrillator (ICD)] implantation, with traditional statistical analysis and machine learning algorithms.
Study Type
Observational
Enrollment (Anticipated)
1618
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yixiu Liang, MD
- Phone Number: +862164041990
- Email: liang.yixiu@zs-hospital.sh.cn
Study Locations
-
-
-
Shanghai, China
- Recruiting
- Zhongshan Hospital
-
Contact:
- Yixiu Liang, MD
- Phone Number: +862164041990
- Email: liang.yixiu@zs-hospital.sh.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The patients who received CRT/ICD implantation for heart failure or high risk of sudden cardiac death (SCD).
Description
Inclusion Criteria:
- all patients who received implantation of CRT/ICD
Exclusion Criteria:
- patients who received generator placement of CRT/ICD
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Zhongshan Hospital cohort
Patients receiving CIED implantation at Zhongshan Hospital
|
The patients received implantation of CRT/ICD.
|
Fuwai Hospital cohort
Patients receiving CIED implantation at Fuwai Hospital
|
The patients received implantation of CRT/ICD.
|
Shanghai Chest Hospital cohort
Patients receiving CIED implantation at Shanghai Chest Hospital
|
The patients received implantation of CRT/ICD.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All-cause mortality
Time Frame: 3 years
|
All-cause death
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yixiu Liang, MD, Shanghai Zhongshan Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2004
Primary Completion (Anticipated)
December 1, 2022
Study Completion (Anticipated)
December 1, 2022
Study Registration Dates
First Submitted
May 25, 2022
First Submitted That Met QC Criteria
May 25, 2022
First Posted (Actual)
May 31, 2022
Study Record Updates
Last Update Posted (Actual)
October 26, 2022
Last Update Submitted That Met QC Criteria
October 25, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PM-CIED
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure, Systolic
-
Central Hospital, Nancy, FranceUnknown
-
Zensun Sci. & Tech. Co., Ltd.Active, not recruitingChronic Systolic Heart FailureChina
-
Zensun Sci. & Tech. Co., Ltd.TerminatedChronic Systolic Heart FailureChina
-
Jiangsu HengRui Medicine Co., Ltd.UnknownChronic Systolic Heart FailureChina
-
Hospital Moinhos de VentoTakedaUnknownHeart Failure, Systolic | Systolic Heart Failure | Cardiac FailureBrazil
-
Merck KGaA, Darmstadt, GermanyMerck Ltd.Completed
-
University of NebraskaEli Lilly and Company; Daiichi Sankyo, Inc.Completed
-
Abbott Medical DevicesCompletedSystolic Heart FailureAustralia, Hong Kong, Japan
-
University of CincinnatiCompletedSystolic Heart FailureUnited States
-
GlaxoSmithKlineCompletedHeart Failure, CongestiveKorea, Republic of
Clinical Trials on CRT/ICD
-
Yonsei UniversityRecruiting
-
Abbott Medical DevicesCompleted
-
Biotronik Japan, Inc.CompletedHeart Failure | Arrhythmias, CardiacJapan
-
Abbott Medical DevicesCompletedSudden Cardiac DeathUnited States
-
LivaNovaCompletedSleep ApnoeaFrance, Italy, Germany, Greece
-
Medtronic Cardiac Rhythm and Heart FailureCompletedHeart Failure | Ventricular Dysfunction | TachyarrhythmiasUnited States, Netherlands, Colombia, South Africa, Japan, Israel, Spain, Canada, United Kingdom, Germany, Slovenia, Sweden, Saudi Arabia, Switzerland, Malaysia, Austria, Czechia, Denmark, India, Italy, United Arab Emirates
-
Prof. Dr. med. Ingo EitelDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)RecruitingNon-ischemic Dilated CardiomyopathyGermany
-
Boston Scientific CorporationGuidant CorporationCompleted
-
Boston Scientific CorporationICON Clinical ResearchCompletedHeart Failure | Arrhythmias, Cardiac | Sudden Cardiac DeathJapan
-
Abbott Medical DevicesCompleted